Amanta Healthcar

40
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
189.95
0.00 (0.00%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 80.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
287.00
650.00
-363.00
-55.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
287.00
650.00
-363.00
-55.85%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-13.00
3.00
23.08%
Raw Materials Consumed
107.00
289.00
-182.00
-62.98%
Power & Fuel Cost
22.00
28.00
-6.00
-21.43%
Employee Cost
42.00
119.00
-77.00
-64.71%
Operating Expenses
25.00
12.00
13.00
108.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
25.00
40.00
-15.00
-37.50%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
29.00
-25.00
-86.21%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
227.00
543.00
-316.00
-58.20%
Operating Profit (PBDIT) excl Other Income
59.00
106.00
-47.00
-44.34%
Other Income
3.00
0.00
3.00
0%
Operating Profit (PBDIT)
63.00
107.00
-44.00
-41.12%
Interest
20.00
29.00
-9.00
-31.03%
Profit before Depriciation and Tax
42.00
77.00
-35.00
-45.45%
Depreciation
18.00
14.00
4.00
28.57%
Profit Before Taxation & Exceptional Items
23.00
63.00
-40.00
-63.49%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
59.00
-38.00
-64.41%
Provision for Tax
6.00
-6.00
12.00
200.00%
Profit After Tax
14.00
66.00
-52.00
-78.79%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
-108.00
136.00
125.93%
Profit Available for appropriations
43.00
-42.00
85.00
202.38%
Appropriations
43.00
-42.00
85.00
202.38%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.33
19.49
-15.16
-77.78%
Profit And Loss - Net Sales
Net Sales 287.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

Profit And Loss - Interest
Interest 20.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 14.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025